Sarepta Therapeutics Inc (SRPT)

Payables turnover

Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020
Cost of revenue (ttm) US$ in thousands 327,818 239,690 185,025 165,885 150,343 136,966 139,892 143,563 139,989 140,934 124,426 106,146 97,049 87,709 79,280 73,106 63,382 56,545 54,567 57,145
Payables US$ in thousands — — — — — — — — — — — — — — — — — — — —
Payables turnover — — — — — — — — — — — — — — — — — — — —

December 31, 2024 calculation

Payables turnover = Cost of revenue (ttm) ÷ Payables
= $327,818K ÷ $—K
= —

The payables turnover ratio for Sarepta Therapeutics Inc is not available as the payables turnover data is not provided in the financial statement information. The payables turnover ratio is a measure of how efficiently a company is managing its payables by comparing the amount of purchases made on credit to the average accounts payable for a period. Unfortunately, without the specific data points required to calculate this ratio, a detailed analysis of Sarepta Therapeutics Inc's payables turnover cannot be provided at this time.